ClinicalTrials.gg
Not yet recruitingNCT07883486Updated Oct 20, 2026

Post-operative Pain and Apical Healing After Root Canal (re)Treatment With Laser-activated Irrigation Versus Sonic or no Activation

An interventional study of sonically activated irrigation and laser activated irrigation in Apical Periodontitis and Post Operative Pain, Acute, sponsored by University Ghent. Not yet recruiting at 2 sites in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by University Ghent · Not applicable, Interventional, and Treatment

Updated Oct 20, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
183
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

When a tooth's nerve dies, inflammation can develop at the tip of the tooth's root. Root canal treatment is carried out to allow this inflammation to heal. Sometimes, inflammation persists in a tooth that has already undergone root canal treatment. In such cases, the root canals may be re-treated to allow the inflammation to heal.

During root canal treatment, the root canals inside the tooth are cleaned and then filled. Various instruments are used to clear the root canal along its entire length, so that the entire canal can be disinfected using antiseptic products. To allow these products to work more effectively, they can be activated. This activation can be achieved, amongst other methods, using vibrations caused by a plastic tip vibrating at a sonic frequency within the liquid. Another method of activation involves the use of a laser, which delivers pulsed energy. This creates shock waves in the liquid. Previous research has shown that root canals can be cleaned more effectively through the use of activation techniques.

This study aims to investigate whether the inflammation present at the root tip heals more effectively following the use of activation methods for the disinfectant. The use of the laser is compared with that of the sonic vibration instrument, and with a group in which the disinfectant is not activated. The effect of the activation method on post-treatment pain is also investigated.

02

Conditions studied

  • Apical Periodontitis
  • Post Operative Pain, Acute
03

In context

Periapical Periodontitis

256 studies on the registry are indexed under Periapical Periodontitis; 65 are open to participants now.

This study's planned enrollment of 183 is above the median of 60 across 222 interventional studies indexed under Periapical Periodontitis.

Browse Periapical Periodontitis studies →

Lead sponsor

University Ghent is the lead sponsor of 349 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients older than 18 years
  • Mature permanent tooth
  • Pulpal diagnosis: pulp necrosis, previously initiated treatment, root filled
  • Apical diagnosis: asymptomatic apical periodontitis
  • Pre-operative pain of 0 on the Visual Analogue Scale (VAS)

Exclusion criteria

Exclusion criteria:

  • Permanent teeth with immature roots or open apices
  • Teeth not eligible for orthograde (re)treatment
  • Teeth with acute pain
  • Teeth with periodontal pockets ≥ 5 mm
  • Teeth with persistent intracanal drainage
  • Non-restorable teeth
  • Pregnant women
  • Patients who took drugs with possible influence on the pain sensation within 12 hours before treatment
  • Patients with pain from one or multiple teeth
  • Patients with contra-indications for the use of NSAID
  • Patients with a known or suspected malignancy
  • Patients with a history of chemotherapy within five years
  • Patients with a history of radiation therapy in the head and neck region
  • Patients with a history of metabolic bone diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
183 participants (estimated)

Study arms

  • Active comparator
    conventional needle irrigation

    Other: conventional needle irrigation

  • Experimental
    sonically activated irrigation

    Device: sonically activated irrigation

  • Experimental
    laser activated irrigation

    Device: laser activated irrigation

Interventions

  • Devicesonically activated irrigation

    The irrigant is activated after mechanical preparation with a plastic Eddy-tip (f = 6000 Hz) inserted up to 1 - 3 mm short of the working length. Three 20 s activation cycles are performed per canal, with 2 mL irrigation in each root canal between the cycles.

  • Devicelaser activated irrigation

    The irrigant is activated after mechanical preparation with a pulsed Er:YAG laser (Fotona Fidelis III, PIPS, E = 20 mJ, f = 20 Hz, t = 50 μs). These settings result in a power of 0.4 W. Due to the high absorption of the Er:YAG wavelength in the irrigant, mechanical effects occur (cavitation), rather than thermal effects. As a result, the risk of thermal damage is negligible. The tip of the laser is kept at the canal orifice, but not inserted into the root canal. During activation, irrigant is continuously added to the pulp chamber, so the root canals and pulp chamber are consistently immersed in irrigating solution. Three 20 s activating cycles per orifice are executed, with intermittent flushing of the root canal with 2 mL irrigant.

  • Otherconventional needle irrigation

    The root canals are irrigated with 3% NaOCl, using a 27G notched needle, adapted to a 3 mL syringe and inserted up to 2 - 3 mm short of working length. Two millilitres of irrigant are used between the different instruments.

06

What researchers measure

Primary outcomes

  1. post-operative pain

    The post-operative pain immediately after completion of treatment is scored with the Visual Analogue Scale (VAS). Patients are asked to fill out a pain diary 6 hours, 24 hours, 48 hours, 72 hours and 96 hours after treatment with a pain score on the VAS.

    Time frame: Post-operative pain is scored immediately after the treatment and 6 hours, 24 hours, 48 hours, 72 hours and 96 hours after treatment.

  2. tooth survival

    presence of the treated tooth inside the mouth

    Time frame: up to 2 years post-treatment

  3. apical healing

    The pre-operative and recall periapical radiographs are compared for the periapical index (PAI). On the radiographs, the apical periodontitis lesion is outlined and the surface of the lesion is calculated using software. The surface of the apical periodontitis lesion on the follow-up radiograph is compared to the pre-operative radiograph. Teeth are categorized into the following three outcome categories based on analysing the change in the PAI: * Strict radiographic success (healed teeth): absence of clinical signs or symptoms, and PAI-score of 1 or 2 at follow-up. * Loose radiographic success (healing teeth): absence of clinical signs or symptoms, and a lower PAI-score (or smaller surface of the lesion) compared to the pre-operative radiograph. * Failure (non-healing): clinical signs or symptoms (including pain, swelling, sinus tract), or asymptomatic with an unchanged PAI-score (or surface of the lesion), or increase in PAI-score (or surface of the lesion) at follow-up.

    Time frame: up to 2 years post-treatment

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Aug 2029, 34 months later.

Of 151 non-industry interventional studies with no phase under Periapical Periodontitis, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 19. This study's planned 34 months is above that.

Counting every sponsor, half of 152 studies reached it within 12 months; a quarter within 6 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2026
First posted
Oct 20, 2026
StartEst.
Oct 2026
Primary completionEst.
Aug 2029
CompletionEst.
Aug 2029
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07883486
Lead sponsor
University Ghent
Responsible party
Sponsor
First posted
Oct 20, 2026
Start date
Oct 2026 (estimated)
Primary completion
Aug 2029 (estimated)
Completion
Aug 2029 (estimated)
Last update
Oct 20, 2026

Study contacts

Mieke De Bruyne, Prof. dr.
Contact
Mieke.DeBruyne@uzgent.be
+3293324020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion